Pacira BioSciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2009 | $-20.8M | $-26.3M | $5.5M | $524.0K |
| FY2010 | $-24.9M | $-31.7M | $6.8M | $23.0K |
| FY2011 | $-31.0M | $-37.2M | $6.2M | $2.5M |
| FY2012 | $-70.1M | $-88.4M | $18.3M | $4.8M |
| FY2013 | $-43.8M | $-56.0M | $12.2M | $11.5M |
| FY2014 | $26.6M | $3.6M | $23.0M | $24.8M |
| FY2015 | $28.0M | $-12.3M | $40.3M | $33.4M |
| FY2016 | $33.5M | $8.7M | $24.7M | $31.2M |
| FY2017 | $17.8M | $-1.5M | $19.3M | $31.6M |
| FY2018 | $48.9M | $34.4M | $14.5M | $31.7M |
| FY2019 | $70.5M | $60.4M | $10.2M | $33.7M |
| FY2020 | $77.0M | $39.2M | $37.8M | $39.9M |
| FY2021 | $125.7M | $79.9M | $45.9M | $42.2M |
| FY2022 | $145.3M | $115.2M | $30.1M | $48.1M |
| FY2023 | $154.6M | $139.5M | $15.2M | $47.9M |
| FY2024 | $189.4M | $178.8M | $10.6M | $51.2M |
| FY2025 | $152.0M | $136.7M | $15.3M | $57.5M |